Various cancer tests

Measuring the number of CTCs (circulating tumor cells) and CSCs (circulating cancer stem cells) in the blood provides an indication of the possibility of recurrence or metastasis, prognosis, and how much post-operative treatment is required.

It can simultaneously test for four types of digestive system cancer: biliary tract cancer, stomach cancer, pancreatic cancer, and colorectal cancer. It has a high test accuracy of 90%, including early detection.

It can check the possibility of having six types of cancer: oral cancer, breast cancer, lung cancer, stomach cancer, pancreatic cancer, and colorectal cancer.

Since the balance of amino acid concentrations differs between healthy people and people with cancer, cancer risk can be assessed by statistically analyzing these differences.

This test detects only highly malignant "mesenchymal cancer cells" that have undergone epithelial-mesenchymal transition with extremely high accuracy among CTCs. It can be used to confirm whether cancer has progressed anywhere in the body or the risk of it progressing in the future.

This test uses just one drop of blood to detect cancer from stage 0. It measures and quantifies minute amounts of cancer-related substances that dissolve into the blood, and classifies and assesses the risk of cancer into three levels.

By examining genes circulating in the blood and genetic abnormalities in blood mononuclear cells, it is possible to evaluate the risk of the presence of minute cancers that are difficult to detect through diagnostic imaging.

It is a genetic test that can be done using only blood. There are two types of MiRTeL tests: the "Telomere Test" aimed at disease prevention, and the "Mir Test" which focuses on early detection of cancer.